Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $595.44 | 30 | 80.4% |
| Education | $145.09 | 3 | 19.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $229.37 | 8 | $0 (2021) |
| Janssen Biotech, Inc. | $99.95 | 1 | $0 (2022) |
| PFIZER INC. | $86.72 | 5 | $0 (2022) |
| Amgen Inc. | $78.71 | 4 | $0 (2022) |
| Seagen Inc. | $68.59 | 4 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $47.08 | 3 | $0 (2022) |
| Deciphera Pharmaceuticals Inc. | $22.83 | 1 | $0 (2022) |
| Epizyme, Inc., | $19.04 | 1 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $18.54 | 1 | $0 (2021) |
| GlaxoSmithKline, LLC. | $17.53 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $319.30 | 14 | Janssen Biotech, Inc. ($99.95) |
| 2021 | $421.23 | 19 | Daiichi Sankyo Inc. ($229.37) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/13/2022 | Amgen Inc. | Kyprolis (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Oncology | ||||||
| 06/02/2022 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: ONCOLOGY | ||||||
| 05/24/2022 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: ONCOLOGY | ||||||
| 05/19/2022 | GlaxoSmithKline, LLC. | BLENREP (Biological) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: ONCOLOGY | ||||||
| 05/18/2022 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: Oncology | ||||||
| 05/10/2022 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Oncology | ||||||
| 05/04/2022 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: ONCOLOGY | ||||||
| 04/25/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Education | In-kind items and services | $99.95 | General |
| Category: Oncology | ||||||
| 04/25/2022 | ARRAY BIOPHARMA INC | MEKTOVI (Drug), BRAFTOVI | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: ONCOLOGY | ||||||
| 04/19/2022 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug), VYXEOS | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 04/06/2022 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Oncology | ||||||
| 03/24/2022 | Amgen Inc. | Kyprolis (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Oncology | ||||||
| 03/23/2022 | Epizyme, Inc., | TAZVERIK (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: ONCOLOGY | ||||||
| 03/16/2022 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2021 | Amgen Inc. | Nplate (Biological), XGEVA | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Hematology | ||||||
| 12/07/2021 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: ONCOLOGY | ||||||
| 11/30/2021 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2021 | PFIZER INC. | IBRANCE (Drug), TALZENNA | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: ONCOLOGY | ||||||
| 11/10/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | MEKINIST (Drug), TAFINLAR, TABRECTA | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2021 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2021 | PFIZER INC. | IBRANCE (Drug) | Education | In-kind items and services | $31.80 | General |
| Category: ONCOLOGY | ||||||
| 10/13/2021 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: ONCOLOGY | ||||||
| 09/09/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.13 | General |
| Category: Cardiovascular | ||||||
| 08/16/2021 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Oncology | ||||||
| 07/28/2021 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 176 | 430 | $204,093 | $29,122 |
| 2022 | 1 | 83 | 162 | $68,910 | $10,595 |
| 2021 | 3 | 247 | 356 | $74,459 | $19,156 |
| 2020 | 2 | 298 | 439 | $83,301 | $17,225 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 110 | 303 | $133,150 | $19,138 | 14.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 43 | 98 | $61,708 | $8,677 | 14.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 29 | $9,235 | $1,307 | 14.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 83 | 162 | $68,910 | $10,595 | 15.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 181 | 286 | $61,490 | $16,335 | 26.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 17 | 19 | $5,472 | $1,526 | 27.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 49 | 51 | $7,497 | $1,295 | 17.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 166 | 276 | $59,340 | $12,264 | 20.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 132 | 163 | $23,961 | $4,961 | 20.7% |
About Jenavieve Rummel, PA-C
Jenavieve Rummel, PA-C is a Medical healthcare provider based in Cartersville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/07/2016. The National Provider Identifier (NPI) number assigned to this provider is 1326408147.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jenavieve Rummel, PA-C has received a total of $740.53 in payments from pharmaceutical and medical device companies, with $319.30 received in 2022. These payments were reported across 33 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($595.44).
As a Medicare-enrolled provider, Rummel has provided services to 804 Medicare beneficiaries, totaling 1,387 services with total Medicare billing of $76,098. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Medical
- Other Specialties Physician Assistant
- Location Cartersville, GA
- Active Since 03/07/2016
- Last Updated 04/05/2022
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1326408147
Products in Payments
- Enhertu (Drug) $229.37
- ERLEADA (Drug) $99.95
- IBRANCE (Drug) $86.72
- Kyprolis (Drug) $62.77
- ADCETRIS (Biological) $51.07
- MEKINIST (Drug) $34.86
- QINLOCK (Drug) $22.83
- TAZVERIK (Drug) $19.04
- LIBTAYO (Biological) $18.54
- BLENREP (Biological) $17.53
- TUKYSA (Drug) $17.52
- Nplate (Biological) $15.94
- ZEPZELCA (Drug) $14.48
- MEKTOVI (Drug) $12.84
- LYNPARZA (Drug) $12.72
- LUTATHERA (Drug) $12.22
- ELIQUIS (Drug) $12.13
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.